Cipher Pharmaceuticals Inc. | |
Stock Exchange | Toronto Stock Exchange Prices |
EPS |
CAD0.12 |
Market Cap |
CAD36.06 M |
Shares Outstanding |
26.91 M |
Public Float |
16.42 M |
Address |
209 Oak Park Boulevard Oakville Ontario L6H 0M2 Canada |
Employees | - |
Website | http://www.cipherpharma.com |
Updated | 07/08/2019 |
Cipher Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the robust and diversified portfolio of commercial and late-stage products. It also acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Its products include Actikerall, Aclaro, Beteflam, Epuris, Vaniqa, Dermadexin, Pruridexin, Ozenoxacin, Lipofen, Conzip, and Durela. |